Selective embolization of thyroid arteries as an alternative treatment of amiodarone-induced hyperthyroidism

Lekarz wojskowy Pub Date : 2022-10-12 DOI:10.53301/lw/147086
Dorota Brodowska-Kania, J. Narloch, P. Piasecki, M. Saracyn, G. Kamiński
{"title":"Selective embolization of thyroid arteries as an alternative treatment of amiodarone-induced hyperthyroidism","authors":"Dorota Brodowska-Kania, J. Narloch, P. Piasecki, M. Saracyn, G. Kamiński","doi":"10.53301/lw/147086","DOIUrl":null,"url":null,"abstract":"Background: A selective embolization of thyroid arteries (SETA) is a rarely performed procedure. Although 35 years have passed since the first description of the SETA application, only about 150-200 procedures have been published so far. Case presentation: We present the case of a patient successfully treated for amiodarone-induced hyperthyroidism using the SETA method. Patient had a history of paroxysmal atrial fibrillation (PAF), diagnosed three years earlier, treated with an anticoagulant - rivaroxaban. During 35 months, amiodarone was used as a method for treating the PAF. During the treatment, the patient developed hyperthyroidism. The patient was treated with thiamazole, propranolol and sodium perchlorate. After obtaining euthyreosis, SETA was performed. The patient underwent selective embolization of the left superior and right inferior thyroid arteries with a sclerosing agent – polyvinyl alcohol with good clinical effect. A thyrosthetics agents were discontinued. Conclusions: This case demonstrates difficulties in differential diagnosis of the type of amiodarone-induced hyperthyroidism. Normal ultrasound image of the thyroid gland and absence of antithyroid antibodies suggests type II of amiodarone-induced hyperthyroidism. While, a good, fast response to thyrostatics – type I. It seems, therefore that, the diagnosis of the mixed type of amiodarone-induced hyperthyroidism is justified. Further research are also required to assess the safety and efficacy of SETA in amiodarone-induced hyperthyroidism in larger groups of patients.","PeriodicalId":86495,"journal":{"name":"Lekarz wojskowy","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lekarz wojskowy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53301/lw/147086","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A selective embolization of thyroid arteries (SETA) is a rarely performed procedure. Although 35 years have passed since the first description of the SETA application, only about 150-200 procedures have been published so far. Case presentation: We present the case of a patient successfully treated for amiodarone-induced hyperthyroidism using the SETA method. Patient had a history of paroxysmal atrial fibrillation (PAF), diagnosed three years earlier, treated with an anticoagulant - rivaroxaban. During 35 months, amiodarone was used as a method for treating the PAF. During the treatment, the patient developed hyperthyroidism. The patient was treated with thiamazole, propranolol and sodium perchlorate. After obtaining euthyreosis, SETA was performed. The patient underwent selective embolization of the left superior and right inferior thyroid arteries with a sclerosing agent – polyvinyl alcohol with good clinical effect. A thyrosthetics agents were discontinued. Conclusions: This case demonstrates difficulties in differential diagnosis of the type of amiodarone-induced hyperthyroidism. Normal ultrasound image of the thyroid gland and absence of antithyroid antibodies suggests type II of amiodarone-induced hyperthyroidism. While, a good, fast response to thyrostatics – type I. It seems, therefore that, the diagnosis of the mixed type of amiodarone-induced hyperthyroidism is justified. Further research are also required to assess the safety and efficacy of SETA in amiodarone-induced hyperthyroidism in larger groups of patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
选择性甲状腺动脉栓塞作为胺碘酮诱导的甲亢的替代治疗
背景:甲状腺动脉选择性栓塞(SETA)是一种罕见的手术。尽管SETA申请的首次描述已经过去了35年,但到目前为止,只公布了大约150-200个程序。病例介绍:我们介绍了一例使用SETA方法成功治疗胺碘酮诱导的甲状腺功能亢进症的患者。患者有阵发性心房颤动(PAF)病史,三年前诊断,接受抗凝剂利伐沙班治疗。在35个月期间,胺碘酮被用作治疗PAF的方法。在治疗过程中,患者出现甲状腺功能亢进。患者接受了噻咪唑、普萘洛尔和高氯酸钠治疗。在获得真hyreosis后,进行SETA。患者用硬化剂聚乙烯醇选择性栓塞甲状腺左上动脉和右下动脉,临床效果良好。停用了一种甲状腺麻醉剂。结论:该病例在胺碘酮诱导的甲状腺功能亢进症的鉴别诊断方面存在困难。甲状腺的正常超声图像和抗甲状腺抗体的缺乏表明胺碘酮诱导的甲状腺功能亢进症为II型。然而,对甲状腺抑制剂I型有良好、快速的反应。因此,胺碘酮诱导的混合型甲状腺功能亢进的诊断似乎是合理的。还需要进一步的研究来评估SETA在胺碘酮诱导的甲状腺功能亢进症大组患者中的安全性和有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Intestinal parasitic infections in Polish soldiers deployed to Kosovo Kaposi's sarcoma in a HIV-positive patient Medical teleconsultations – new possibilities and legal and ethical dilemmas Organizational standards for medical teleconsultations and personal data protection The fulfilment of patients’ rights in the provision of teleconsultations during the COVID-19 epidemic state from the viewpoint of administrative decisions in proceedings in case of practices violating collective patient’s rights
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1